USPTO serial 79448423
4TISSUE
Reviewed by CopyMark Law Group
Status 645Office Action
- Filing date
- Status date
- Registration date
- —
- Examiner
- CARR, PATRICK C
- Law office
- TMO LAW OFFICE 125
What this means
The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.
Need help with 4TISSUE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Office Action, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Clifford D. Hyra
Clifford D. Hyra Fresh IP PLC11710 Plaza America DriveSuite 2000Reston, VA 20190Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Medical preparations aimed at restoring the function of cells, tissues and organs, being medical preparations for the treatment of soft tissue defects and wound healing; Medical products, namely, implantable natural scaffolds mimicking the extracellular matrix aimed at functional restoration of cells, tissues and organs; Medical preparations and products that serve as carriers for drugs, cells and cell derivatives, such as stem cells for medical purposes | ACTIVE | — |
| 042 | Research, design and development services in the field of biomaterials, regenerative medicine and drug delivery systems; Medical research in the field of regenerative medicine and drug delivery systems; Conducting scientific studies in the field of biomaterials, regenerative medicine and drug delivery systems; Testing and inspection services in the field of biomaterials, regenerative medicine and drug delivery systems, being the inspection of medical, medicinal, pharmaceutical or combinational products for quality control purposes; Scientific laboratory services; Scientific and medical research and development relating to products, technologies and treatments in the field of regenerative medicine and drug delivery systems for market approval through clinical validation and conducting clinical trials related thereto; Culturing cells and tissues for others for scientific research purposes; Synthesis of biomaterials for scientific research services | ACTIVE | — |
| 044 | Medical services in the field of regenerative medicine and drug delivery systems; Medical treatments, being medical services involving the treatment of soft tissue defects using injections, implants, and the oral, topical and external administration, in the field of regenerative medicine and drug delivery systems; Medical laboratory analysis services relating to the analysis of medic(in)al products; Medical advice in the field of regenerative medicine and drug delivery systems; Providing medical information in the field of regenerative medicine and drug delivery systems | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 5, 2026 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Oct 5, 2026 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Oct 5, 2026 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Sep 3, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 3, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 3, 2026 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 27, 2026 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jul 16, 2026 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jun 27, 2026 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jun 27, 2026 | RFRR | REFUSAL PROCESSED BY MPU | — |
| May 2, 2026 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| May 1, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 28, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 27, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Apr 27, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 23, 2026 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |